In this pilot study, we examined leukemic cells from ten patients with CLL in relation to their capacity for adhesion to stromal cells and the sensitivity of this adhesion to inhibitors of the 5-LOX pathway (zileuton and MK886). The gene discussed is ALOX5; the disease is B-cell chronic lymphocytic leukemia.